Lemaitre Vascular LMAT
NASDAQ LMAT
$78.29 +0.64 (+0.82%)
At close: Nov 13, 2026 · 4:00 PM EST

Lemaitre Vascular (LMAT) Return on Sales [ROS] (2009 - 2026)

Updated

Lemaitre Vascular (LMAT) posted Return on Sales [ROS] of 26.03% for Q3 2026, down 7.24 percentage points from 33.27% a year earlier and down 2.95 percentage points from the prior quarter.

Analysis

Lemaitre Vascular (LMAT) Return on Sales [ROS] (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Return on Sales [ROS] at Lemaitre Vascular was 27.73%, up 2.02 percentage points year-over-year; for FY2025, it was 27.21%, up 3.44 percentage points from FY2024.

  • Annual Return on Sales [ROS] has increased for three consecutive years, with a five-year change of +4.95 percentage points (FY2020 to FY2025).
  • In prior years, Lemaitre Vascular's Return on Sales [ROS] was 23.77% in FY2024 (+4.79 pp), 18.97% in FY2023 (+2.38 pp), 16.60% in FY2022 (-6.99 pp) and 23.59% in FY2021 (+1.33 pp).
  • The Q3 2026 figure stands as the lowest quarterly Return on Sales [ROS] since Q2 2025.
  • On a year-over-year basis, Return on Sales [ROS] increased in five of the last eight quarters, with an average year-over-year change of +2.27 percentage points.
  • The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q3 2025, with a gain of 9.29 percentage points; the weakest was Q2 2022, with a drop of 13.57 percentage points.
  • According to Business Quant data, Return on Sales [ROS] for the three prior quarters was 28.98% (Q2 2026), 26.71% (Q1 2026) and 29.22% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn 18.65%
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn 10.44%
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn 19.00%
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn 19.44%
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn 18.08%
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn 15.86%
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn 16.12%
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn 17.44%
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn 6.36%
10 Lemaitre Vascular 1.79 Bn 299.03 Mn 48.71 Mn 26.03%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 26.03%
Jun 30, 2026 28.98%
Mar 31, 2026 26.71%
Dec 31, 2025 29.22%
Sep 30, 2025 33.27%
Jun 30, 2025 25.13%
Mar 31, 2025 21.09%
Dec 31, 2024 23.07%
Sep 30, 2024 23.98%
Jun 30, 2024 25.75%
Mar 31, 2024 22.20%
Dec 31, 2023 20.88%
Sep 30, 2023 19.36%
Jun 30, 2023 18.86%
Mar 31, 2023 16.73%
Dec 31, 2022 17.01%
Sep 30, 2022 15.76%
Jun 30, 2022 13.74%
Mar 31, 2022 20.04%
Dec 31, 2021 21.01%
API Access

Lemaitre Vascular Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=LMAT&period=max&api_key=YOUR_API_KEY